Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer
Clinical trial NCT03647839 · COMPLETED
Trial details
- NCT number
- NCT03647839
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-06
- Primary completion
- 2021-01-29
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.